Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.
Elizabeth A. Kichula, MD, PhD
Advertisement
Assistant Professor of Clinical Neurology, Perelman School of Medicine, University of Pennsylvania; Attending Physician, Children's Hospital of Philadelphia
Articles by Elizabeth A. Kichula, MD, PhD
Advertisement
Latest Updated Articles
Highly Effective Gene Therapies for SMA: Where Do We Go From Here?Published: August 16th 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Clinical Review of the 2025 Restless Leg Syndrome Guidelines
2
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
3
CAPN2-Targeting Agent AMX0114 Shows Safe Profile in Phase 1 LUMINA Trial of ALS
4
Challenges with Commonly Available Dopamine Agonists in Parkinson’s Disease
5